- 全部删除
- 您的购物车当前为空
D-K6L9表现出针对囊性纤维化患者中的P. aeruginosa具有抗菌(antimicrobial)及抗生物膜效应,能稳定抵抗囊性纤维化痰中的蛋白酶降解,且不诱发细菌耐药性。
D-K6L9表现出针对囊性纤维化患者中的P. aeruginosa具有抗菌(antimicrobial)及抗生物膜效应,能稳定抵抗囊性纤维化痰中的蛋白酶降解,且不诱发细菌耐药性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 待询 | 待询 | |
50 mg | 待询 | 待询 |
D-K6L9 相关产品
产品描述 | D-K6L9 exhibits antimicrobial and antibiofilm properties effective against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. The compound demonstrates stability and resistance to degradation by proteases found in cystic fibrosis sputum and does not promote bacterial resistance [1]. |
分子量 | 1804.48 |
分子式 | C90H174N22O15 |
CAS No. | 426264-61-1 |
Sequence | Leu-Lys-{d-Leu}-Leu-Lys-{d-Lys}-Leu-{d-Leu}-{d-Lys}-Lys-Leu-Leu-{d-Lys}-Leu-Leu-NH2 |
Sequence Short | LK-{d-Leu}-LK-{d-Lys}-L-{d-Leu}-{d-Lys}-KLL-{d-Lys}-LL-NH2 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容